World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
58
Citations
14922
World Ranking
3385
National Ranking
298

Herren Wu publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Herren Wu sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 177 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Herren Wu D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Herren Wu sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 58 D-Index — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Herren Wu is affiliated with AstraZeneca in the United Kingdom. Their research spans fields such as Biochemistry, Genetics and Molecular Biology, and Medicine. Within these fields, the primary subfields of study include Molecular Biology, Oncology, Cancer Research, Immunology and Allergy, and Radiology, Nuclear Medicine and Imaging.

The scientist's work focuses on topics such as RNA Interference and Gene Delivery, Advanced Biosensing and Bioanalysis Techniques, S100 Proteins and Annexins, Protease and Inhibitor Mechanisms, Cell Adhesion Molecules Research, Monoclonal and Polyclonal Antibodies Research, and Lipid Membrane Structure and Behavior.

Herren Wu has published several papers across multiple scientific venues. Notable recent papers include:

  • Engineering Caveolae-Targeted Lipid Nanoparticles To Deliver mRNA to the Lungs, 2020, ACS Chemical Biology
  • Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR, 2021, Molecular Cancer Therapeutics
  • Metabolite-Based Modification of Poly(l-lysine) for Improved Gene Delivery, 2020, Biomacromolecules
  • A Hoechst Reporter Enables Visualization of Drug Engagement In Vitro and In Vivo: Toward Safe and Effective Nanodrug Delivery, 2022, ACS Nano
  • Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models, 2020, PLoS ONE

The frequent publication venues where Herren Wu appears include:

  • PLoS ONE
  • ACS Chemical Biology
  • Molecular Cancer Therapeutics
  • Biomacromolecules
  • ACS Nano

Collaboration is evident in Herren Wu's work, with frequent coauthors including William F. Dall'Acqua, Norman Peterson, M. Jack Borrok, Melissa Damschroder, and Kevin Allen.

Best Publications

  • Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.

    Jane Tian;Ana Maria Avalos;Su-Yau Mao;Bo Chen

  • Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.

    Herren Wu;Ying Nie;William D Huse;Jeffry D Watkins

  • Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)

    William F. Dall'Acqua;Peter A. Kiener;Herren Wu

  • MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.

    Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng

  • Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.

    Herren Wu;David S. Pfarr;Syd Johnson;Yambasu A. Brewah

  • Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences

    William F. Dall’ Acqua;Robert M. Woods;E. Sally Ward;Susan R. Palaszynski

  • Stepwise in vitro affinity maturation of Vitaxin, an αvβ3-specific humanized mAb

    Herren Wu;Gregory Beuerlein;Ying Nie;Heidi Smith

  • A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

    John Y. Li;Samuel R. Perry;Vanessa Muniz-Medina;Xinzhong Wang

  • Ultra-potent antibodies against respiratory syncytial virus: effects of binding kinetics and binding valence on viral neutralization

    Herren Wu;David S. Pfarr;Ying Tang;Ling-Ling An

  • Modulation of the effector functions of a human IgG1 through engineering of its hinge region.

    William F. Dall’Acqua;Kimberly E. Cook;Melissa M. Damschroder;Robert M. Woods

  • Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms.

    Vaheh Oganesyan;Melissa M. Damschroder;Kimberly E. Cook;Qing Li

  • DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo

    Ji-Liang Li;Richard C.A. Sainson;Chern Ein Oon;Helen Turley

  • Structural characterization of a human Fc fragment engineered for lack of effector functions.

    Vaheh Oganesyan;Changshou Gao;Lena Shirinian;Herren Wu

  • Humanization of antibodies

    William Dall-Acqua;Melissa Damschroder;Herren Wu

  • Methods of optimizing antibody variable region binding affinity

    William D. Huse;Jeffry D. Watkins;Herren Wu

  • Antibody humanization by framework shuffling

    William F. Dall’Acqua;Melissa M. Damschroder;Jingli Zhang;Robert M. Woods

  • Multispecific epitope binding proteins and uses thereof

    Herren Wu;Changshou Gao;Carl Hay;Nazzareno Dimasi

  • Respiratory Syncytial Virus-Neutralizing Monoclonal Antibodies Motavizumab and Palivizumab Inhibit Fusion

    Kelly Huang;Len Incognito;Xing Cheng;Nancy D. Ulbrandt

  • Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab.

    H. Wu;D. S. Pfarr;G. A. Losonsky;P. A. Kiener

  • A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

    Dowdy Jackson;John Gooya;Shenlan Mao;Krista Kinneer

Frequent Co-Authors

Peter A. Kiener
Peter A. Kiener AstraZeneca (United Kingdom)
Scott Koenig
Scott Koenig MacroGenics (United States)
Ronald Herbst
Ronald Herbst Biolojic Design
Anthony J. Coyle
Anthony J. Coyle Takeda (United States)
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
Alejandro Aruffo
Alejandro Aruffo Syngenta (United States)
Jürgen Bajorath
Jürgen Bajorath University of Bonn
Genevieve Losonsky
Genevieve Losonsky University of Maryland, Baltimore
Thomas F. Tedder
Thomas F. Tedder Duke University
Peter D. Senter
Peter D. Senter Seattle Genetics (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology through an online degree can open doors to various healthcare and science-related careers. Beyond traditional laboratory work, many graduates consider paths in health information management, a field where professionals oversee patient data and healthcare systems. Understanding the roles and earning potential in this area is crucial, which can be explored further in the health information management job description and salary overview.

For those interested in entering this field, pursuing an accredited online program is essential. Programs like the accredited online health information management degree cahiim ensure that students receive quality education aligned with industry standards and can qualify for certification.

Alternatively, accelerated medical billing and coding certificate programs online offer a quicker pathway into the healthcare administration sector. These courses provide targeted training for managing billing systems and medical codes, which are vital aspects of healthcare operations. You can find more about these opportunities in the accelerated medical billing and coding certificate online section.

Moreover, the growing availability of online medical programs allows students to advance their knowledge and skills in related medical fields from anywhere. This flexibility is especially beneficial for microbiology students seeking to complement their expertise with clinical or administrative medical qualifications.

Best Scientists Citing Herren Wu

Trending Scientists

Recently Published Articles